CG Oncology Files 8-K Report
Ticker: CGON · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1991792
| Field | Detail |
|---|---|
| Company | Cg Oncology, Inc. (CGON) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
TL;DR
CG Oncology filed an 8-K, likely containing important updates. Check for details.
AI Summary
On March 24, 2025, CG Oncology, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates CG Oncology, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial or operational risks.
Key Players & Entities
- CG Oncology, Inc. (company) — Registrant
- March 24, 2025 (date) — Date of Report
- 001-41925 (company) — Commission File Number
- 37-1611499 (company) — IRS Employer Identification No.
- 400 Spectrum Center Drive Suite 2040 (company) — Principal Executive Offices Address
- Irvine, California (company) — Principal Executive Offices Location
- 92618 (company) — Principal Executive Offices Zip Code
- (949) 409-3700 (company) — Registrant's Telephone Number
FAQ
What specific event triggered this 8-K filing?
The filing indicates it is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, with items concerning Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, but the specific triggering event is not detailed in the provided text.
What is the primary business of CG Oncology, Inc.?
CG Oncology, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When was CG Oncology, Inc. incorporated?
CG Oncology, Inc. was incorporated in Delaware.
What is the fiscal year end for CG Oncology, Inc.?
The fiscal year end for CG Oncology, Inc. is December 31st.
Where are CG Oncology, Inc.'s principal executive offices located?
CG Oncology, Inc.'s principal executive offices are located at 400 Spectrum Center Drive, Suite 2040, Irvine, California, 92618.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding CG Oncology, Inc. (CGON).